In short
Clinical trials are investigating Sodium Hypochlorite in people with diabetic foot ulcers. These studies aim to see how well it helps healing and how it compares with other local antimicrobial treatments. The main focus is on treatment effect, time to healing, and patient outcomes in an interventional Phase 3 study.
Key points
- Clinical trial data for Sodium Hypochlorite focus on diabetic foot ulcers. The study is an interventional Phase 3 trial with 202 planned participants. It uses a randomized double-blind design and compares treatment effects on healing. The main endpoint is the time from treatment start to wound healing over 24 weeks. The trial is authorised and is aimed at patients with diabetic foot ulcers.
Trial overview
The available trial data show one interventional study of Sodium Hypochlorite in people with diabetic foot ulcer. The study is authorised and includes 202 participants.
The trial title describes a randomized double-blind comparison of Hypochlorous Acid and Polyhexamethylene biguanide for treating diabetic foot ulcers, while the intervention list names Sodium Hypochlorite for cutaneous use.
Who is being studied
The target population is patients with diabetic foot ulcers. The source data do not provide more detailed inclusion or exclusion rules, so the main known group is people who have this wound condition.
This matters because diabetic foot ulcers can be difficult to heal, so trials often focus on treatments that may improve wound closure over time.
Trial design and phase
This study is a Phase 3 trial, which means it is testing the treatment in a larger group and looking closely at how well it works. It is also randomized and double-blind, which helps make the comparison between treatment groups more fair.
Randomized means people are assigned by chance to a treatment group. Double-blind means the patient and the study team do not know which treatment is being given, which helps reduce bias in the results.
What the trial measures
The main endpoint is the difference in time from baseline, which is the start of the study, to healing. The study measures this over 24 weeks and uses a hazard ratio to compare the groups.
In simple terms, the trial is asking whether one treatment helps wounds heal faster than the other. The brief summary says the main aim is to evaluate time to healing and the efficiency of local antimicrobial agents in complete diabetic foot ulcer healing.
What the trial compares
The title shows that the study compares Hypochlorous Acid with Polyhexamethylene biguanide in treating diabetic foot ulcers. The intervention record also lists Sodium Hypochlorite for cutaneous use, so the trial data link Sodium Hypochlorite to this wound treatment study.
This is a comparative trial, meaning researchers are looking at one treatment against another to see which one performs better for healing.
Why this trial matters
Diabetic foot ulcers can take a long time to heal, so studies like this focus on faster and more complete wound healing. The trial is designed to provide evidence on whether the studied treatment approach can improve healing time in this patient group.
Because the trial is Phase 3 and includes 202 participants, it is part of later-stage clinical research that may help clarify how the treatment performs in real patients with diabetic foot ulcers.